27.04.2015 - Cell therapy company apceth GmbH & Co. KG has expanded its senior management team by appointing Ulrike Verzetnitsch as Chief Technical Officer. Ulrike takes on the role with immediate effect and will lead all of apceth’s production activities and manufacturing operations and continue the expansion of apceth’s GMP manufacturing business.
She brings a wealth of experience gathered in the pharmaceutical sector from her roles in leading pharma and biotech companies. Prior to joining apceth, Ulrike was the Head of the Production Unit at Takeda in Singen. Before that she held the position of Director of Production with Baxter. As part of her role, she gained professional experience in the manufacturing of products for worldwide distribution in compliance with the FDA, EMEA and Japanese and other guidelines.
Ulrike began her career in the pharma industry in 2000. She holds a degree in Biochemistry and a Master’s Degree in Chemical Engineering from the Technical University in Vienna.http://www.european-biotechnology-news.com/people/bio-people/2015/ulrike-verzetnitsch.html